Literature DB >> 7631088

Ventroposterolateral pallidotomy.

L V Laitinen1.   

Abstract

Recent laboratory experiments have produced increasing evidence that nigral-striatal dopamine deficiency causes an inhibitory hyperactivity in the medial globus pallidus (MGP), where it freezes the initiation of movement and thus causes bradykinesia, rigidity and tremor. Surgical lesions in the ventroposterolateral (VPL) pallidum in man not only improve the parkinsonian bradykinesia, but also the tremor, rigidity, and the L-dopa-induced dyskinesias disappear or diminish. The present study shows that VPL pallidotomy improves several psychomotor functions, such as walking speed and manual dexterity. Right-sided VPL thalamotomy also increases the speed and accuracy in verbal performance. Ventrolateral thalamotomy increases bradykinesia. The findings support the concept that the parkinsonian symptoms in man develop in the MGP. Intact pathways from MGP via thalamus to the premotor and motor cortex seem necessary for normal motor functioning. The author also discusses the mechanisms of pallidotomy and thalamotomy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7631088     DOI: 10.1159/000098596

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  4 in total

1.  Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease.

Authors:  G Vingerhoets; C van der Linden; E Lannoo; V Vandewalle; J Caemaert; M Wolters; D Van den Abbeele
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

2.  Usefulness of pallidotomy in advanced Parkinson's disease.

Authors:  F Johansson; J Malm; E Nordh; M Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 3.  Functional anatomy of movement disorders.

Authors:  A R Crossman
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

4.  Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.

Authors:  P K Pal; A Samii; A Kishore; M Schulzer; E Mak; S Yardley; I M Turnbull; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.